Clinical Trial Update: A Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05) [Phase 1]

View source ↗

Summary

Phase 1 trial of evorpacept (ALX148) in combination with venetoclax and azacitidine for adults with acute myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Evorpacept (ALX148) (evorpacept)
• Venetoclax (venetoclax)

Snippet

Sponsor: ALX Oncology Inc. | Conditions: Acute Myeloid Leukemia, AML, Adult | Phase 1 | Status: TERMINATED